FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890572495> ?p ?o ?g. }

• W2890572495 abstract "Vanishing White Matter (VWM) disease is an autosomal genetic leukodystrophy caused by mutations in subunits of eukaryotic translation initiation factor 2B (eIF2B). The clinical symptoms exhibit progressive loss of white matter in both hemispheres of the brain, accompanied by motor functions deterioration, neurological deficits and early death. To date there is no treatment for VWM disease. The aim of this work was to expedite rational development of a therapeutic opportunity. Our approach was to design computer-aided strategy for an efficient and reliable screening of drug-like molecules; and to use primary cultures of fibroblasts isolated from the Eif2b5R132H/R132H VWM mouse model for screening. The abnormal mitochondria content phenotype of the mutant cells was chosen as a read-out for a simple cell-based fluorescent assay to assess the effect of the tested compounds. We obtained a hit rate of 0.04% (20 hits out of 50,000 compounds from the selected library). All primary hits decreased mitochondria content and brought it closer to WT levels. Structural similarities between our primary hits and other compounds with known targets allowed the identification of three putative cellular pathways/targets: 11-HSD1, Sonic hedgehog (Shh), and Sigma-1-Receptor (S1R). In addition to initial experimental indication of Shh pathway impairment in VWM mouse brains, the current study provides evidence that S1R is a relevant target for pharmaceutical intervention for potential treatment of the disease. Specifically, we found lower expression level of S1R protein in fibroblasts, astrocytes and whole brains isolated from Eif2b5R132H/R132H compared to WT mice, and confirmed that one of the hits is a direct binder of S1R, acting as agonist. Furthermore, we provide evidence that treatment of mutant mouse fibroblasts and astrocytes with various S1R agonists corrects the functional impairments of their mitochondria and prevent their need to increase their mitochondria content for compensation purposes. Moreover, S1R activation enhances the survival rate of mutant cells under ER-stress conditions, bringing it to WT levels. This study marks S1R as a target for drug development towards treatment of VWM disease. Moreover, it further establishes the important connection between white matter well-being and S1R-mediated proper mitochondria/ER function." @default.
• W2890572495 created "2018-09-27" @default.
• W2890572495 creator A5010899423 @default.
• W2890572495 creator A5014634783 @default.
• W2890572495 creator A5053258430 @default.
• W2890572495 creator A5062458625 @default.
• W2890572495 creator A5078330026 @default.
• W2890572495 creator A5083177528 @default.
• W2890572495 date "2018-09-18" @default.
• W2890572495 modified "2023-10-06" @default.
• W2890572495 title "Drug Screening Identifies Sigma-1-Receptor as a Target for the Therapy of VWM Leukodystrophy" @default.
• W2890572495 cites W1510407036 @default.
• W2890572495 cites W1938480220 @default.
• W2890572495 cites W1977039024 @default.
• W2890572495 cites W1986310191 @default.
• W2890572495 cites W1994289493 @default.
• W2890572495 cites W1994662145 @default.
• W2890572495 cites W2002439304 @default.
• W2890572495 cites W2007522795 @default.
• W2890572495 cites W2007786647 @default.
• W2890572495 cites W2019079031 @default.
• W2890572495 cites W2019485775 @default.
• W2890572495 cites W2027272574 @default.
• W2890572495 cites W2030740190 @default.
• W2890572495 cites W2038218877 @default.
• W2890572495 cites W2060722219 @default.
• W2890572495 cites W2062473455 @default.
• W2890572495 cites W2062572831 @default.
• W2890572495 cites W2064924737 @default.
• W2890572495 cites W2067040999 @default.
• W2890572495 cites W2068048197 @default.
• W2890572495 cites W2090455515 @default.
• W2890572495 cites W2093620371 @default.
• W2890572495 cites W2093672336 @default.
• W2890572495 cites W2106289426 @default.
• W2890572495 cites W2106322477 @default.
• W2890572495 cites W2118871798 @default.
• W2890572495 cites W2133069858 @default.
• W2890572495 cites W2148992111 @default.
• W2890572495 cites W2156053468 @default.
• W2890572495 cites W2158988264 @default.
• W2890572495 cites W2161015852 @default.
• W2890572495 cites W2166350495 @default.
• W2890572495 cites W2171015665 @default.
• W2890572495 cites W2178386353 @default.
• W2890572495 cites W2189675843 @default.
• W2890572495 cites W2227917434 @default.
• W2890572495 cites W2271406622 @default.
• W2890572495 cites W2283649807 @default.
• W2890572495 cites W2298673178 @default.
• W2890572495 cites W2324665266 @default.
• W2890572495 cites W2474599166 @default.
• W2890572495 cites W2501743136 @default.
• W2890572495 cites W2547401413 @default.
• W2890572495 cites W2559598785 @default.
• W2890572495 cites W2595612075 @default.
• W2890572495 cites W2595836464 @default.
• W2890572495 cites W2609435610 @default.
• W2890572495 cites W2612729272 @default.
• W2890572495 cites W2762815035 @default.
• W2890572495 cites W2765112327 @default.
• W2890572495 cites W2788135342 @default.
• W2890572495 cites W2794506661 @default.
• W2890572495 cites W2840677322 @default.
• W2890572495 cites W4241667541 @default.
• W2890572495 doi "https://doi.org/10.3389/fnmol.2018.00336" @default.
• W2890572495 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6153319" @default.
• W2890572495 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30279648" @default.
• W2890572495 hasPublicationYear "2018" @default.
• W2890572495 type Work @default.
• W2890572495 sameAs 2890572495 @default.
• W2890572495 citedByCount "19" @default.
• W2890572495 countsByYear W28905724952019 @default.
• W2890572495 countsByYear W28905724952020 @default.
• W2890572495 countsByYear W28905724952021 @default.
• W2890572495 countsByYear W28905724952022 @default.
• W2890572495 countsByYear W28905724952023 @default.
• W2890572495 crossrefType "journal-article" @default.
• W2890572495 hasAuthorship W2890572495A5010899423 @default.
• W2890572495 hasAuthorship W2890572495A5014634783 @default.
• W2890572495 hasAuthorship W2890572495A5053258430 @default.
• W2890572495 hasAuthorship W2890572495A5062458625 @default.
• W2890572495 hasAuthorship W2890572495A5078330026 @default.
• W2890572495 hasAuthorship W2890572495A5083177528 @default.
• W2890572495 hasBestOaLocation W28905724951 @default.
• W2890572495 hasConcept C103133801 @default.
• W2890572495 hasConcept C104317684 @default.
• W2890572495 hasConcept C105580179 @default.
• W2890572495 hasConcept C126838900 @default.
• W2890572495 hasConcept C142724271 @default.
• W2890572495 hasConcept C143409427 @default.
• W2890572495 hasConcept C149364088 @default.
• W2890572495 hasConcept C169760540 @default.
• W2890572495 hasConcept C170493617 @default.
• W2890572495 hasConcept C173396325 @default.
• W2890572495 hasConcept C2776100374 @default.
• W2890572495 hasConcept C2776637008 @default.
• W2890572495 hasConcept C2778938600 @default.
• W2890572495 hasConcept C2779134260 @default.
• W2890572495 hasConcept C2780035454 @default.

• next